Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 39

1.
2.

Clinical Presentations and Comparative Outcomes of Delayed-Onset Low-Grade Endophthalmitis Managed with or Without Intraocular Lens Explantation.

Dave VP, Parmeshwarappa DC, Dogra A, Pappuru RR, Pathengay A, Joseph J, Das T.

Clin Ophthalmol. 2020 Feb 26;14:551-555. doi: 10.2147/OPTH.S243496. eCollection 2020.

3.

Aspergillus Endophthalmitis: Clinical Presentations and Factors Determining Outcomes.

Dave VP, Pappuru RR, Pathengay A, Gupta R, Joseph J, Sharma S, Das T.

Asia Pac J Ophthalmol (Phila). 2020 Jan-Feb;9(1):9-13. doi: 10.1097/01.APO.0000617928.43993.7e.

4.

CLINICAL PRESENTATIONS, DIAGNOSIS, AND MANAGEMENT OUTCOMES OF CURVULARIA ENDOPHTHALMITIS AND A REVIEW OF LITERATURE.

Dave VP, Joseph J, Pathengay A, Pappuru RR, Das T.

Retina. 2020 Feb;40(2):370-375. doi: 10.1097/IAE.0000000000002375.

PMID:
31972808
5.

Detection of Torque Teno Virus (TTV) and TTV-Like Minivirus in patients with presumed infectious endophthalmitis in India.

Naik P, Dave VP, Joseph J.

PLoS One. 2020 Jan 7;15(1):e0227121. doi: 10.1371/journal.pone.0227121. eCollection 2020.

6.

Enterobacter endophthalmitis: Clinical settings, susceptibility profile, and management outcomes across two decades.

Dave VP, Pathengay A, Behera S, Joseph J, Sharma S, Pappuru RR, Das T.

Indian J Ophthalmol. 2020 Jan;68(1):112-117. doi: 10.4103/ijo.IJO_693_19.

7.

Does ophthalmic-grade silicone oil possess antimicrobial properties?

Dave VP, Joseph J, Jayabhasker P, Pappuru RR, Pathengay A, Das T.

J Ophthalmic Inflamm Infect. 2019 Nov 1;9(1):20. doi: 10.1186/s12348-019-0187-6.

8.

Targeted High-Throughput Sequencing Identifies Predominantly Fungal Pathogens in Patients with Clinically Infectious, Culture-Negative Endophthalmitis in South India.

Gandhi J, Jayasudha R, Naik P, Sharma S, Dave VP, Joseph J.

Microorganisms. 2019 Oct 1;7(10). pii: E411. doi: 10.3390/microorganisms7100411.

9.

Vitreous D-Lactate Levels as a Biomarker in the Diagnosis of Presumed Infectious Culture Negative Endophthalmitis.

Naik P, Singh S, Dave VP, Ali MH, Kumar A, Joseph J.

Curr Eye Res. 2020 Feb;45(2):184-189. doi: 10.1080/02713683.2019.1662057. Epub 2019 Sep 13.

PMID:
31466487
10.

Learning curve of a trained vitreo-retinal surgeon in sub-retinal injections in a rat model: Implications for future clinical trials.

Dave VP, Susaimanickam PJ, Mir IA, Mariappan I, Basu S, Reddy BG, Pappuru RR, Jalali S, Das T.

Indian J Ophthalmol. 2019 Sep;67(9):1455-1458. doi: 10.4103/ijo.IJO_317_19.

11.

Infectious endophthalmitis leading to evisceration: spectrum of bacterial and fungal pathogens and antibacterial susceptibility profile.

Dave TV, Dave VP, Sharma S, Karolia R, Joseph J, Pathengay A, Pappuru RR, Das T.

J Ophthalmic Inflamm Infect. 2019 May 16;9(1):9. doi: 10.1186/s12348-019-0174-y.

12.

Trends in microbiological spectrum of endophthalmitis at a single tertiary care ophthalmic hospital in India: a review of 25 years.

Joseph J, Sontam B, Guda SJM, Gandhi J, Sharma S, Tyagi M, Dave VP, Das T.

Eye (Lond). 2019 Jul;33(7):1090-1095. doi: 10.1038/s41433-019-0380-8. Epub 2019 Feb 21.

PMID:
30792523
13.

Endoscopic vitrectomy in endophthalmitis: initial experience of 33 cases at a tertiary eye care center.

Dave VP, Pappuru RR, Tyagi M, Pathengay A, Das T.

Clin Ophthalmol. 2019 Feb 5;13:243-251. doi: 10.2147/OPTH.S185716. eCollection 2019.

14.

ENTEROCOCCUS ENDOPHTHALMITIS: Clinical Settings, Antimicrobial Susceptibility, and Management Outcomes.

Dave VP, Pathengay A, Braimah IZ, Panchal B, Sharma S, Pappuru RR, Mathai A, Tyagi M, Narayanan R, Jalali S, Das T.

Retina. 2019 Jan 23. doi: 10.1097/IAE.0000000000002462. [Epub ahead of print]

PMID:
30681640
15.

Reply.

Dave VP, Pathengay A, Sharma S, Naveen N, Basu S, Pappuru RR, Das T.

Am J Ophthalmol. 2019 Mar;199:258. doi: 10.1016/j.ajo.2018.10.024. Epub 2018 Dec 15. No abstract available.

PMID:
30563613
16.

Vitrectomy with Silicone Oil Tamponade in Rhegmatogenous Retinal Detachment following Acute Retinal Necrosis: Clinical Outcomes and Prognostic Factors.

Dave VP, Pappuru RR, Pathengay A, Tyagi M, Narayanan R, Jalali S.

Semin Ophthalmol. 2018 Nov 29:1-5. doi: 10.1080/08820538.2018.1551907. [Epub ahead of print]

PMID:
30496028
17.

Clinical presentations, management outcomes, and diagnostic dilemma in Kocuria endophthalmitis.

Dave VP, Joseph J, Pathengay A, Pappuru RR.

J Ophthalmic Inflamm Infect. 2018 Nov 20;8(1):21. doi: 10.1186/s12348-018-0163-6.

18.

CLINICAL PRESENTATIONS, DIAGNOSIS, AND MANAGEMENT OUTCOMES OF CURVULARIA ENDOPHTHALMITIS AND A REVIEW OF LITERATURE.

Dave VP, Joseph J, Pathengay A, Pappuru RR, Das T.

Retina. 2018 Oct 23. doi: 10.1097/IAE.0000000000002375. [Epub ahead of print]

PMID:
30358762
19.

Filamentous gram-negative bacteria masquerading as actinomycetes in infectious endophthalmitis: a review of three cases.

Joseph J, Sharma S, Dave VP.

J Ophthalmic Inflamm Infect. 2018 Oct 11;8(1):15. doi: 10.1186/s12348-018-0157-4.

20.

Diagnosis, Clinical Presentations, and Outcomes of Nocardia Endophthalmitis.

Dave VP, Pathengay A, Sharma S, Naveen N, Basu S, Pappuru RR, Das T.

Am J Ophthalmol. 2019 Jan;197:53-58. doi: 10.1016/j.ajo.2018.09.007. Epub 2018 Sep 19.

PMID:
30240723

Supplemental Content

Loading ...
Support Center